Multiple

Nuvei Announces Filing of Management Proxy Circular and Receipt of Interim Order in Relation to Go-Private Arrangement

Retrieved on: 
星期二, 五月 14, 2024
Holiday, Interim order, EDGAR, Proxy, CDPQ, Letter, Telephone, TD Securities, Advent International, Person, Minority, Hierarchy, Consideration, Committee, Schedule, Circular, Multiple, Meeting, Court, Superior court, Arrangement, Canada Business Corporations Act, TSX, Security (finance)

The Special Committee was advised by independent legal counsel and retained TD Securities Inc. ("TD") as financial advisor and independent valuator.

Key Points: 
  • The Special Committee was advised by independent legal counsel and retained TD Securities Inc. ("TD") as financial advisor and independent valuator.
  • The Circular contains a detailed description of the Arrangement and includes additional information to assist in considering how to vote at the Meeting.
  • The Plan of Arrangement and a copy of the Arrangement Agreement are available under Nuvei's profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov .
  • The Company has retained Kingsdale Advisors to provide a broad array of strategic advisory, governance, strategic communications, digital and investor campaign services.

Human-Centered Digital Technology Starts with Digital Talent Development: DigiBridge Digital Talent Development Side Event at the 2024 UN STI Forum

Retrieved on: 
星期六, 五月 11, 2024
Assembly, Shantou University, Digital divide, United Nations University, Research, Development, Workplace, Interdisciplinarity, Developed country, Intelligence, Sustainable Development Goals, Digital, Chairperson, Founding, WDTA, United Nations, Generative, Innovation, Creativity, Synthetic media, Entrepreneurship, Microsoft, Education, University, UQ, General assembly, Digital technology, Multiple, Student, ROI, Ministry of Social Affairs, UN, Big data, Assistant, AI, Poverty, Growth, Emerging, Economy, Digital inclusion, Medical device

A key highlight of the forum was the DigiBridge side event, organized by the World Digital Technology Academy (WDTA).

Key Points: 
  • A key highlight of the forum was the DigiBridge side event, organized by the World Digital Technology Academy (WDTA).
  • The event centered on crucial discussions about narrowing the global talent and skill gap and enabling developing countries to leverage digital technologies for sustainable growth.
  • Yale Li, Co-Founder and Executive Chairman of WDTA, introduced the highly anticipated 'DigiBridge Digital Talent Development Program.
  • The success of the DigiBridge side event at the 2024 UN STI Forum underscored the critical importance of international collaboration in tackling challenges of the digital era.

Global Applications for 2024 Young Scientist SDGs Award are Officially Open!

Retrieved on: 
星期四, 五月 9, 2024
Well, United Nations, University, Climate, Drinking, Award, Good Health, Tsinghua University, Research, Multiple, Engineering, United, Life, Science, Sustainable Development Goals, SDG7, Multimedia, SDG6, City University, Civilization, Letter, Organization, Young

WENZHOU, China, May 9, 2024 /PRNewswire/ -- The global applications for 2024 Young Scientist Sustainable Development Goals Award (Young Scientist SDGs Award for short) are open from April 30, 2024 until July 31, 2024 (Beijing time).

Key Points: 
  • WENZHOU, China, May 9, 2024 /PRNewswire/ -- The global applications for 2024 Young Scientist Sustainable Development Goals Award (Young Scientist SDGs Award for short) are open from April 30, 2024 until July 31, 2024 (Beijing time).
  • Recognizing that the future of science and technology is dependent on today' s youth, the Wenzhou Growth Foundation for World Young Scientists and the World Association of Young Scientists (WAYS (preparatory)) are cooperating with the International Research Center of Big Data for Sustainable Development Goals (CBAS) to initiate the "Young Scientist Sustainable Development Goals Award" (Young Scientist SDGs Award).
  • The 2024 Young Scientist SDGs Award ceremony will be held during the main session of the 2024 World Young Scientist Summit in early November 2024.
  • At the opening ceremony of the 2023 World Young Scientist Summit, three young professors were given the inaugural Young Scientist SDGs Award.

Nuvei Announces First Quarter 2024 Results

Retrieved on: 
星期二, 五月 7, 2024
Advent International, Total, CDPQ, SMB, Share (finance), Hierarchy, Hand, TSX, Income Tax Act, Public expenditure, Multiple, Toronto Stock Exchange, Internal Revenue Code, ISV, Three Months, Pro forma, Ratio, Canada Business Corporations Act, Minority, Nuvei, Bank statement, Government, Advent, Letter, Cryptocurrency

MONTREAL, May 7, 2024 /PRNewswire/ -- Nuvei Corporation ("Nuvei" or the "Company") (Nasdaq: NVEI) (TSX: NVEI), the Canadian fintech company, today reported its financial results for the three months ended  March 31, 2024. The Company's results are also included in a quarterly shareholder letter which can be found in the "Events and presentations" and "Financial information" sections of the Company's Investor Relations website at https://investors.nuvei.com.

Key Points: 
  • MONTREAL, May 7, 2024 /PRNewswire/ -- Nuvei Corporation ("Nuvei" or the "Company") (Nasdaq: NVEI) (TSX: NVEI), the Canadian fintech company, today reported its financial results for the three months ended  March 31, 2024.
  • SMB revenue increased 1% year over year on a pro forma(a) basis, to $79 million and represented 24% of total revenue in the first quarter.
  • In summary, total revenue increased 11% year over year on a pro forma(a) basis in the first quarter.
  • Nuvei today announced that its Board of Directors has authorized and declared a cash dividend of $0.10 per Subordinate Voting Share and Multiple Voting Share, payable on June 6, 2024 to shareholders of record on May 21, 2024.

The Inner Circle Acknowledges, Divyakant B. Gandhi, MBBS, FRCS, FACS, Circle as a Distinguished Cardiothoracic Surgeon

Retrieved on: 
星期一, 五月 6, 2024
Doctor of Philosophy, Education, Atrial fibrillation, Cardiothoracic surgery, American College, Multimedia, Lung cancer, MBBS, Coronary artery disease, Mentorship, Ohio State University, Ventricular septal defect, Elective surgery, Heart, Parent, Research, University, FACS, Multiple, Lung, Inner circle, McLaren Health Care Corporation, Patient, Medicine, Circulatory system, Physician, Intellectual property, Health, Mitral valve, FRCS, Student, General surgery, Quality of life, Georgia Tech, Medical college, Royal, Royal college

Divyakant B. Gandhi is an international physician, innovative thinker, and leader in cardiac care.

Key Points: 
  • Divyakant B. Gandhi is an international physician, innovative thinker, and leader in cardiac care.
  • He has been in practice as a Heart, Lung & Vascular surgeon for over 35 years.
  • As a leader in the clinical setting, Dr. Gandhi is the Chief of Staff, Medical Director, and Chief of Cardiovascular & Thoracic Surgery at McLaren Greater Lansing.
  • Dr. Gandhi practices his specialty under the auspices of the Center for Cardiovascular and Thoracic Surgery in Detroit, MI.

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

Retrieved on: 
星期三, 三月 27, 2024
Multiple, Professor, ETV, SAN, Patient, Hepatology, Southern Medical University, SHBG, Doctor of Science, University, Doctor of Philosophy, MBBS, MASH, MBA, Science, Therapy, Hepatitis, Part, Division, University of Hong Kong, Infection, CHB, Pharmaceutical industry

The poster presentation highlights ALG-055009 Phase 1 data that showed multiple-ascending doses (MAD) over 14 days in hyperlipidemic subjects produced favorable, dose-dependent pharmacodynamic effects on atherogenic lipids and sex hormone binding globulin (SHBG), an indicator of target engagement in the liver.

Key Points: 
  • The poster presentation highlights ALG-055009 Phase 1 data that showed multiple-ascending doses (MAD) over 14 days in hyperlipidemic subjects produced favorable, dose-dependent pharmacodynamic effects on atherogenic lipids and sex hormone binding globulin (SHBG), an indicator of target engagement in the liver.
  • “We are pleased to present these additional Phase 1 data for ALG-055009 and ALG-000184 at APASL 2024.
  • We continue to believe our molecule has the potential to be best-in-class,” said Lawrence Blatt, Ph.D., MBA, Chairman, President, and Chief Executive Officer at Aligos Therapeutics.
  • “In addition, the three ALG-000184 oral presentations demonstrate a consistent effect in the reduction of key viral markers.

Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update

Retrieved on: 
星期二, 三月 26, 2024
GAAP, Research, GBA1, Multiple, Therapy, G&A, Safety

BETHESDA, Md., March 26, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today reports financial results for the year ended December 31, 2023 and provides a corporate update.

Key Points: 
  • BETHESDA, Md., March 26, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today reports financial results for the year ended December 31, 2023 and provides a corporate update.
  • We believe our cash position and operational plans are strong and allow us to meet our near-term milestones,” said Matthias Alder, Gain Therapeutics’ CEO.
  • Research and development (R&D) expenses increased by $3.1 million to $11.5 million for the year ended December 31, 2023, from $8.4 million for the year ended December 31, 2022.
  • Net loss as of December 31, 2023 included non-cash compensation expenses of $3.3 million as compared to 2022 non-cash compensation expenses of $1.5 million.

Auto Dealership Buy/Sell Market Achieves New Transaction Record in 2023, Surpassing 2021 Peak; Valuations Remain at All Time Highs for Top Franchises in High Growth Markets

Retrieved on: 
星期二, 四月 9, 2024
Consulting, EV, Electric Vehicles, Automotive, Professional Services, Business, Marketing, Advertising, Communications, Other Automotive, General Automotive, Finance, Lincoln, Volvo, Face, Growth, Asbury Automotive Group, Original equipment manufacturer, Big Three (automobile manufacturers), Partnership, Risk, Multiple, Kerrigan, Sale, Acquisition, Ford, ICE, BMW, OEM, Toyota Financial Services, Population growth, Car dealership

The auto dealership buy/sell market’s outperformance relative to the broader corporate M&A market is, according to the report, a result of its distinctly private structure.

Key Points: 
  • The auto dealership buy/sell market’s outperformance relative to the broader corporate M&A market is, according to the report, a result of its distinctly private structure.
  • “When earnings soared in 2021, buyers correctly projected that pandemic earnings were unsustainable and normalized earnings for valuation purposes.
  • The public dealership groups acquired 61 franchises for $2.7 billion in 2023, the second highest US acquisition spending level on record.
  • The Kerrigan Auto Retail Index is designed to track dealership valuation trends, while also providing key insights into factors influencing auto retail.

Artmarket.com: the Artprice100© index was up 1.55% in 2023

Retrieved on: 
星期四, 四月 4, 2024
Surrealism, Print, Annual report, ROI, Art market, Old Master, Multiple, Fine art, Female, Sale, Suggestion, Euronext Paris, Artprice, Contemporary art, Century

"Artprice's latest annual report, "The Art Market in 2023" underscores the shift from a sellers' market to a buyers' market in 2023, explains thierry Ehrmann, CEO and Founder of Artmarket.com and its Artprice department.

Key Points: 
  • "Artprice's latest annual report, "The Art Market in 2023" underscores the shift from a sellers' market to a buyers' market in 2023, explains thierry Ehrmann, CEO and Founder of Artmarket.com and its Artprice department.
  • The exact breakdown of the portfolio as of 1 January 2023 is provided below in the section Composition of Artprice100© as of 1 January 2023.
  • The investment in works by Jean-Michel Basquiat (1960-1988) represented 3.9% of the portfolio at the start of 2023, but his price index fell by -15% in 2023.
  • Modern Art remained the largest segment in the composition of the Artprice100© index, accounting for 43% of the initial 2023 investment.

Artmarket.com: the Artprice100© index was up 1.55% in 2023

Retrieved on: 
星期四, 四月 4, 2024
Surrealism, Print, Annual report, ROI, Art market, Old Master, Multiple, Fine art, Female, Sale, Suggestion, Euronext Paris, Artprice, Contemporary art, Century

"Artprice's latest annual report, "The Art Market in 2023" underscores the shift from a sellers' market to a buyers' market in 2023, explains thierry Ehrmann, CEO and Founder of Artmarket.com and its Artprice department.

Key Points: 
  • "Artprice's latest annual report, "The Art Market in 2023" underscores the shift from a sellers' market to a buyers' market in 2023, explains thierry Ehrmann, CEO and Founder of Artmarket.com and its Artprice department.
  • The exact breakdown of the portfolio as of 1 January 2023 is provided below in the section Composition of Artprice100© as of 1 January 2023.
  • The investment in works by Jean-Michel Basquiat (1960-1988) represented 3.9% of the portfolio at the start of 2023, but his price index fell by -15% in 2023.
  • Modern Art remained the largest segment in the composition of the Artprice100© index, accounting for 43% of the initial 2023 investment.